Grant Status Currently Funded
Division Division of Cancer Control and Population Sciences
Program Epidemiology and Genomics Research Program (EGRP)
Branch Clinical and Translational Epidemiology Branch
PI Name Organization Name Project Title
(Click for Abstract, Pubs, etc.)
Grant Number Initiative
(Click for Funding Announcement)
Awarded Dollars Fiscal Year Abstract Page URL Funding Announcement URL
Afshar-Kharghan, Vahid University of TX MD Anderson Can Ctr Genetics of Graft-Versus-Host Disease 5R01CA231141-04 PA16-160 281522 2021
Akbilgic, Oguz Wake Forest University Health Sciences Early Identification of Childhood Cancer Survivors at High Risk for Late Onset Cardiomyopathy: an Artificial Intelligence Approach Utilizing Electrocardiography 1R01CA261834-01A1 CA20-027 563803 2022
Anderson, Garnet L. Fred Hutchinson Cancer Research Center Life and Longevity After Cancer (LILAC): the Women's Health Initiative Cancer Survivor Cohort 5U01CA173642-08 PAR17-233 1554023 2021
Baker, Kevin S Fred Hutchinson Cancer Research Center Integrating Health Informatics in a Scalable Stepped Care Self-Management Program for Survivors After Hematopoietic Cell Transplantation 5R01CA215134-05 PA16-160 560444 2022
Banack, Hailey Rose State University of New York at Buffalo Ms. Lilac: Muscle Mass in the Life and Longevity After Cancer (LILAC) Study 1R37CA258761-01A1 PA20-185 728401 2022
Bates, Melissa Lowe University of Iowa Sleep Disordered Breathing as a Targetable Risk Factor in Multiple Myeloma 1R01CA244271-01A1 PA20-185 584230 2022
Berger, Michael F. Sloan-Kettering Inst Can Research (PQ3) Integrative Biomarkers of Cancer Progression and Therapeutic Response From Germline and Somatic Clinical Sequencing 5R01CA227534-04 CA18-019 697766 2022
Berwick, Marianne University of New Mexico Health Scis Ctr Integration of Clinical and Molecular Biomarkers for Melanoma Survival 3P01CA206980-05S1 PAR15-023 112686 2021
Berwick, Marianne University of New Mexico Health Scis Ctr Integration of Clinical and Molecular Biomarkers for Melanoma Survival 5P01CA206980-05 PAR15-023 1987168 2021
Beyer, Kirsten M Medical College of Wisconsin Racism, Residential Racial Segregation, and Breast Cancer Survival Disparities Among Black, Hispanic and Non-Hispanic White Women 5R01CA214805-05 PA13-292 558055 2021
Bhatia, Smita University of Alabama at Birmingham Bmt Survivor Study-2 (Bmtss-2) 5U01CA213140-04 PAR17-233 1254755 2022
Binder, Alexandra Margaret Lynn University of Hawaii at Manoa Characterizing the Risk of Chemotherapy Side Effects Based on Epigenetic Age and Modification By Resistance Training Intervention 1R37CA263064-01 PA20-185 549396 2021
Buring, Julie E. Brigham and Women's Hospital Women's Health Study: Infrastructure Support for Cohort Follow-Up 5U01CA182913-08 PAR17-233 715304 2021
Burridge, Paul W. Northwestern University at Chicago Genomic Prediction of Doxorubicin-Induced Cardiotoxicity 5R01CA220002-04 CA17-017 339052 2021
Burridge, Paul W. Northwestern University at Chicago Predicting and Preventing Chemotherapy-Induced Cardiotoxicity in African American Children 1R01CA261898-01 CA20-027 684513 2021
Burridge, Paul W. Northwestern University at Chicago Assessing the Ability of Hicms to Recapitulate Patient-Specific Doxorubicin-Induced Cardiotoxicity 3R01CA220002-04S1 PA20-222 76544 2021
Cai, Tianxi Harvard School of Public Health Semi-Supervised Algorithms for Risk Assessment with Noisy Ehr Data 5R21CA242940-02 PAR15-334 177510 2020
Camp, Nicola J. University of Utah INTERLYMPH: at the Forefront of International Lymphoma Research 1R13CA250183-01 PA18-648 12000 2020
Carey, Lisa A Univ of North Carolina Chapel Hill Optimizing Her2-Targeting Using Rna and DNA-Based Predictive Algorithms 5R01CA229409-03 PA18-484 542931 2021
Cerhan, James R Mayo Clinic Rochester The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study 5U01CA195568-07 PAR17-233 1938064 2022
Cheng, Ting-Yuan University of Florida Energy Balance, Mtor Pathway Signaling, and Breast Cancer Prognosis 5R37CA248371-02 PA19-056 557538 2022
Christensen, Brock Clarke Dartmouth College (PQ3) Immune Epigenetic Biomarkers of Bladder Cancer Outcomes 5R01CA216265-05 CA15-008 472491 2021
Christiani, David C Harvard School of Public Health The Boston Lung Cancer Survival Cohort 5U01CA209414-05 PAR15-104 1275710 2021
Claus, Elizabeth B. Yale University Optimizing Engagement in Discovery of Molecular Evolution of Low Grade Glioma (OPTIMUM) 1U2CCA252979-01A1 CA19-045 3122950 2021
Cook, Linda S University of Colorado Denver A Population Based Study of Ketorolac and Ovarian Cancer Survival 5R01CA236789-04 PA19-056 338423 2022
Demirci, F. Yesim University of Pittsburgh at Pittsburgh Metabolomic and Mirna Profiling of Vitreous Humor in Uveal Melanoma 1R21CA241840-01A1 PAR19-277 415342 2020
Diefenbach, Catherine Sibyl New York University School of Medicine A Prospective Evaluation of the Gut Microbiome as a Mediator of Lymphoma Treatment Outcome and Systemic Immunity 1R01CA269617-01 PA20-185 717936 2022
Doherty, Jennifer Anne University of Utah Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: an Integrative Approach 5R01CA243188-02 PA19-056 1386624 2021
Fedirko, Veronika University of TX MD Anderson Can Ctr Gut Microbiome and Cancer Immunotherapy Outcomes in Advanced Renal Cell Carcinoma 1R01CA255322-01A1 PA20-185 638550 2022
Figueiredo, Jane C. Cedars-Sinai Medical Center Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators 1R01CA258222-01 CA20-004 779477 2021
Friedman, Debra L Vanderbilt University Medical Center Research Into Visual Endpoints and Rb Health Outcomes After Treatment: the Riverboat Consortium 5R01CA225005-04 PA16-160 169382 2021
Friedman, Debra L Vanderbilt University Medical Center CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan 1UG3CA260318-01 CA20-030 1076143 2021
Furberg-Barnes, Anna Helena Sloan-Kettering Inst Can Research Body Composition and the Obesity Paradox in Clear Cell Renal Cell Carcinoma 5R01CA233885-03 PA18-484 653307 2021
Gomez, Scarlett L University of California, San Francisco Insights From Asian Populations Into Disparities in Breast Cancer Prognosis and Outcomes 5R01CA241125-02 PA19-056 1067902 2021
Gong, Zhihong Roswell Park Cancer Institute Corp Long Noncoding Rna Regulations in Breast Cancer Among African-American Women 5R01CA246688-02 PAR18-869 391107 2021
Gonzalez, Brian D. H. Lee Moffitt Cancer Ctr & Res Inst Identifying and Reducing Disparities in Patient-Reported Outcomes Among African American Prostate Cancer Survivors 5R01CA242742-02 PA19-056 380399 2021
Goode, Ellen L. Mayo Clinic Rochester Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk 5R01CA248288-02 PA19-056 998304 2022
Hahn, Theresa E Roswell Park Cancer Institute Corp Multi-Ethnic High-Throughput Study to Identify Novel Non-Hla Genetic Contributors to Mortality After Blood and Marrow Transplantation 1R01CA262899-01 PA20-185 954265 2021
Harris, Holly Ruth Fred Hutchinson Cancer Research Center Type II Diabetes, Related Biomarkers and Medications, and Ovarian Cancer Risk 1R03CA267113-01 PAR20-052 88000 2022
Hashibe, Mia University of Utah Long-Term Adverse Outcomes Among Rural Cancer Survivors in a Population-Based Cohort 5R01CA244326-02 PA17-289 486574 2021
Henry, Norah Lynn University of Michigan at Ann Arbor Inflammatory Oxylipins and Aromatase Inhibitor Toxicity in Breast Cancer 1R21CA251343-01A1 PAR19-277 427833 2021
Hines, Robert Brooks University of Central Florida Prevention and Treatment of Oxaliplatin-Induced Peripheral Neuropathy 1R03CA241788-01A1 PAR18-021 149000 2020
Hudson, Melissa M St. Jude Children's Research Hospital Brain Age in Adult Survivors of Childhood Leukemia and Cns Tumor 3U01CA195547-07S1 PA18-591 448748 2021
Hudson, Melissa M St. Jude Children's Research Hospital The St. Jude Lifetime Cohort 5U01CA195547-07 PAR17-233 1242454 2021
Hundley, William Gregory Wake Forest University Health Sciences Understanding and Predicting Fatigue, Cv Decline & Events After Breast CA Treatment 5R01CA199167-05 PA13-302 419244 2021
Hurtado De Mendoza Casaus, Alejandra Georgetown University Testing a Culturally Targeted Narrative Video to Reduce Disparities in the Use of Genetic Counseling and Testing in Latina Women at-Risk of Hboc 5R01CA248543-02 PAR18-559 506851 2022
Im, Cindy University of Alberta Treatment-Specific Genetic Risk Scores for Late Effects Prediction in Childhood, Adolescent, and Young Adult Cancer Survivors 1R21CA261833-01 CA20-028 279068 2021
Kantor, Elizabeth David Sloan-Kettering Inst Can Research Obesity, Chemotherapy Dosing, and Breast Cancer Outcomes 5R37CA222793-05 PA16-160 504753 2022
Kaphingst, Kimberly A University of Utah Leveraging an Electronic Medical Record Infrastructure to Identify Primary Care Patients Eligible for Genetic Testing for Hereditary Cancer and Evaluate Novel Cancer Genetics Service Delivery Models 5U01CA232826-04 CA17-041 1024795 2021
Kensler, Kevin Hughes Weill Medical Coll of Cornell Univ Contributions of Tumor Molecular Subtypes to Prostate Cancer Racial Disparities 5R00CA245900-04 CA19-029 195879 2022
Kirchhoff, Anne C University of Utah Identifying the Role of Short-Term Fine Particulate Matter Air Pollution in the Heart and Lung Health Outcomes of Adolescent and Young Adult Cancer Survivors 5R03CA256263-02 PAR20-052 76250 2022
Kraft, Peter Harvard School of Public Health Multifactoral Breast Cancer Risk Prediction Accounting for Ethnic and Tumor Diversity 5U01CA249866-02 PA19-056 637691 2021
Kroenke, Candyce H Kaiser Foundation Research Institute Social Networks and Disparities in Health Behaviors and Breast Cancer Outcomes in Immigrant Women 5R01CA230440-03 PA17-041 670002 2021
Krull, Kevin R St. Jude Children's Research Hospital Sleep Apnea in Survivors of Childhood Cancer Treated with Thoracic Radiation (Apnea 5R01CA215405-05 PA16-160 565224 2021
Kurian, Allison W. Stanford University Genetic Testing, Treatment Use, and Mortality After Diagnosis of Breast and Ovarian Cancer: the Georgia-California Genelink Initiative 5R01CA225697-04 PA16-160 247753 2021
Kushi, Lawrence H Kaiser Foundation Research Institute Breast White Adipose Tissue Inflammation and Breast Cancer Outcomes 5R01CA241409-03 PA19-056 926607 2022
Kushi, Lawrence H Kaiser Foundation Research Institute Infrastructure for Pathways, a Prospective Study of Breast Cancer Survivorship 2U01CA195565-06 PAR17-233 2000990 2021
Kwan, Marilyn L Kaiser Foundation Research Institute Predictors of Cvd Among Breast Cancer Survivors in an Integrated Health System 5R01CA214057-04 PA16-035 618653 2020
Li, Guojun University of TX MD Anderson Can Ctr Immuno-Inflammatory Response Non-Coding Rnas as Predictors of HPV Status & Outcome of Oropharyngeal Cancer Patients 5R01CA236859-03 PA19-056 363602 2022
Luo, Juhua Trustees of Indiana University Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Lung Cancer Prognosis 5R03CA256238-02 PAR20-052 79250 2022
Marcotte, Erin University of Minnesota Socioeconomic Determinants of Childhood Cancer Outcomes in a Large Contemporary Cohort 1R01CA266105-01 PA20-185 579707 2022
Mccormack, Valerie International Agency for Res on Cancer African Breast Cancer - Disparities in Outcomes - Plus (Abc-Do Plus) 5R01CA244559-03 PA19-056 231503 2022
Mendoza, Tito R University of TX MD Anderson Can Ctr Use of Patient-Reported Outcomes in Understanding Symptomatic Adverse Events in Early-Phase Trials of Combination Treatments That Include Immune Checkpoint Inhibitors and Targeted Therapy 5R01CA242565-03 PAR18-869 358680 2022
Milam, Joel E University of California-Irvine Project Milestones: Young Adult Cancer Survivorship 5R01CA237230-03 PA18-484 415390 2022
Moskowitz, Chaya Sloan-Kettering Inst Can Research International Study of Subsequent Colorectal Cancer Among Survivors of Childhood, Adolescent, and Young Adult Cancers (I-Scry) 1R01CA268143-01 PAR18-869 431445 2022
Nathanson, Katherine L. University of Pennsylvania Randomized Trial of Universal Vs. Guideline-Directed Germline Testing Among Young Adults with Cancer 1U01CA232836-01A1 CA19-017 4815109 2019
Nichols, Hazel B Univ of North Carolina Chapel Hill In Vitro Fertilization Outcomes After Cancer 5R01CA211093-03 PA18-484 124621 2021
Nyante, Sarah Jane Univ of North Carolina Chapel Hill Breast Cancer Neoadjuvant Endocrine Therapy During the COVID-19 Pandemic: Opportunity for a New Treatment Paradigm? 1R21CA270625-01 PAR19-277 181741 2022
Offit, Kenneth Sloan-Kettering Inst Can Research The Impact of DNA Damage Repair Abnormalities in Prostate Cancer 5P01CA228696-02 PAR18-290 1783381 2021
Paczesny, Sophie Medical University of South Carolina Machine Learning to Identify Biomarkers for Risk of Chronic Graft-Versus-Host Disease 1R01CA264921-01A1 PA20-185 628188 2022
Pal, Tuya Vanderbilt University Medical Center Breast Cancer in Blacks: Impact of Genomics, Healthcare Use and Lifestyle on Outcomes (BRIGHT) 5R01CA204819-05 PAR15-093 368599 2021
Park, Yikyung Washington University Dietary Patterns and Cardiovascular Disease Risk in Childhood Cancer Survivors: St. Jude Lifetime Cohort 1R03CA252485-01 PAR18-021 182771 2020
Parsons, Susan Kenyon Tufts Medical Center Modeling Multi-Source Data in Hodgkin Lymphoma 1R01CA262265-01A1 PA20-185 827059 2022
Penedo, Frank J University of Miami Coral Gables Avanzando Caminos (Leading Pathways): the Hispanic/Latino Cancer Survivorship Cohort Study.” 5UG3CA260317-02 CA20-030 955889 2022
Penney, Kathryn L Brigham and Women's Hospital Comprehensive Characterization of Prostate Stromal Gene Expression and Association with Lethal Prostate Cancer 5R37CA227190-05 PA16-160 514572 2022
Peres, Lauren Cole H. Lee Moffitt Cancer Ctr & Res Inst The Role of Inflammation in the Racial Disparities in Ovarian Cancer Survival 5R00CA218681-04 PA16-193 247267 2020
Pestell, Richard G Baruch S. Blumberg Institute Ccr5 Inhibitors to Enhance Therapeutic Response of Breast Cancer to DNA Damaging Agents 1R21CA235139-01A1 PA19-111 382756 2020
Phipps, Amanda Irene Fred Hutchinson Cancer Research Center Serrated Colorectal Cancer: an Emerging Disease Subtype 5R01CA196337-06 PA13-302 343891 2020
Platz, Elizabeth A. Johns Hopkins University Stromal Senescence in Lethal Prostate Cancer: a Novel Target for Prognosis and Therapy 5R01CA255349-02 PA19-056 411778 2022
Poisson, Laila M Henry Ford Health System Molecular and Clinical Evaluation of the Glioma Patient Experience to Anticipate Modern Outcomes and Guide Patient Care 5R01CA222146-04 PA16-160 346510 2021
Rahm, Alanna K Geisinger Clinic Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizational Contexts 5R01CA211723-05 PAR16-238 637674 2021
Reif, David M North Carolina State University Raleigh Genetic Etiology of Cancer Drug Response 5R01CA161608-09 PA16-160 411604 2021
Reyes-Gibby, Cielito C University of TX MD Anderson Can Ctr Improving Emergency Care and Outcomes of Immune-Related Adverse Events: the Immune-Related Emergency Disposition Index (IREDI) 1R01CA267856-01 PA20-185 709427 2022
Rohan, Thomas E Albert Einstein College of Medicine Tmem, Menacalc, and Menainv as Prognostic and Predictive Markers for Breast Cancer Metastasis 5R01CA240646-02 PA19-056 852124 2021
Schildkraut, Joellen M. Emory University Ovarian Cancer Survival in African-American Women 5R01CA237318-02 PA19-056 1293151 2021
Schwartz, Ann G. Wayne State University Detroit Research on Cancer Survivors (Detroit Rocs) 2U01CA199240-06 PAR20-294 1077655 2022
Skolarus, Ted Albert University of Michigan at Ann Arbor Refining Castration Use for Recurrent Prostate Cancer 5R01CA242559-03 PA19-056 335650 2022
Slager, Susan L. Mayo Clinic Rochester Integration of Germline and Tumor Genomes in Cll 5R01CA235026-04 PA18-484 633873 2022
Sweet, Kevin M. Ohio State University A Randomized Controlled Trial: Genetic Counseling Patient Preference Intervention Via Electronic Health Record Portal Vs. Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer 5R01CA248739-02 PAR18-559 580791 2022
Syngal, Sapna Dana-Farber Cancer Inst Development and Validation of Clinical Prediction Models for the Use and Interpretation of Multigene Hereditary Cancer Risk Assessment 5R01CA132829-13 PA16-160 446335 2022
Thomas, Nancy E Univ of North Carolina Chapel Hill Identification of Lethal Melanomas at the Time of Diagnosis 5R01CA233524-03 PA19-056 897329 2022
Thompson, Caroline Avery Univ of North Carolina Chapel Hill Diagnosis of Cancer in the Emergency Room - Explaining Persistent Disparities 7R01CA264176-02 PA21-268 352620 2021
Traube, Chani Weill Medical Coll of Cornell Univ Delirium in Children Undergoing Hematopoietic Stem Cell Transplants 5R01CA244500-02 PA19-056 657848 2021
Travis, Lois B. Indiana Univ-Purdue Univ at Indianapolis Genetic Susceptibility and Biomarkers of Platinum-Related Toxicities 5R01CA157823-08 PA19-056 336985 2021
Tyekucheva, Svitlana Dana-Farber Cancer Inst Curated Prostate Cancer Data for Novel and Reproducible Prognostic Modeling 5R21CA241647-02 PA17-243 173649 2021
Ulrich, Cornelia M. University of Utah Metabolomic Strategies for Discovery and Validation of Biomarkers of Colorectal Cancer Recurrence 5R01CA207371-05 PA16-160 868657 2022
Ulrich, Cornelia M. University of Utah Transdisciplinary Team Science in Colorectal Cancer Prognosis: the Colocare Study 2U01CA206110-06 PAR20-294 1936657 2021
Wallace, Kristin Medical University of South Carolina The Immune Contexture of Colorectal Adenomas and Serrated Polyps 5R01CA226086-04 PA18-484 597781 2021
Warren Andersen, Shaneda University of Wisconsin-Madison Understanding the Contribution of Colorectal Cancer Tumor Characteristics to Disparities in Colorectal Cancer Survival 1R01CA255318-01A1 PA20-185 684014 2021
Weaver, Kathryn Elizabeth Wake Forest University Health Sciences Assessing Efficacy and Implementation of an Ehr Tool to Assess Heart Health Among Survivors 5R01CA226078-04 PA16-035 474908 2022
Wesselmann, Ursula Isolde University of Alabama at Birmingham Life After Breast Cancer Treatment: Racial Health Disparities and Chronic Pain in Breast Cancer Survivors. 5R01CA246708-02 PAR18-869 339694 2021
Wiencke, John K. University of California, San Francisco Immune Epigenetic Biomarkers of Survival in Glioma Epidemiology 5R01CA207360-05 PA16-160 543240 2021
Wiesner, Georgia L Vanderbilt University Medical Center Improving Identification and Healthcare for Patients with Inherited Cancer Syndromes: Evidence-Based Emr Implementation Using a Web-Based Computer Platform 1U01CA232829-01A1 CA19-017 5339027 2019
Yao, Song Roswell Park Cancer Institute Corp Disparities in Results of Immune Checkpoint Inhibitor Treatment (DIRECT): a Prospective Cohort Study of Cancer Survivors Treated with Anti-pd-1/Anti-pd-l1 in a Community Oncology Setting 1UG3CA260602-01 CA20-030 1059896 2021
Yasui, Yutaka St. Jude Children's Research Hospital Late Effects Prediction Using Clinical Phenotypes and Whole Genome Sequencing 5R01CA216354-05 PAR16-218 628281 2021
Zhang, Jianjun University of TX MD Anderson Can Ctr The Molecular and Immune Evolution in the Progression of Lung Neoplasia to Invasive Adenocarcinoma 5R01CA234629-04 PA17-459 366000 2022